Tribute to Livingston’s many achievements during nearly a half-century at Dana-Farber
Dana-Farber Cancer Institute shared a post on X:
“In an outpouring of support and to ensure that the late, Dr. David Livingston’s legacy will endure, nearly 200 of his family members, friends, and past trainees; Dana-Farber Trustees; professional colleagues from Dana-Farber, Dana-Farber/Harvard Cancer Center, and beyond; and grant-makers who supported his work over the years came together to fund an endowed chair in his honor. The David M. Livingston, MD, Chair at Dana-Farber pays tribute to Livingston’s many achievements during nearly a half-century at Dana-Farber.
The endowed chair will support the work of Pasi A. Jänne, MD, PhD, as the first incumbent. A leading cancer scientist, Jänne will leverage the chair to continue to make fundamental clinical and basic science discoveries that will change how lung cancer is treated and continue Livingston’s legacy by mentoring the next generation of oncology experts.”
Source: Dana-Farber Cancer Institute/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023